Radian Group's third-quarter report marks a milestone in the company's transformation from a mortgage insurer into a diversified, multi-line specialty insurer. The Inigo acquisition has reshaped Radian's revenue mix, and this quarter offered investors the clearest look yet at how that deal is translating into top-line growth and profitability. With total revenue more than doubling year over year, the results signal that the company's diversification strategy is gaining traction. For shareholders, the key questions center on whether specialty insurance momentum can offset a softening mortgage insurance environment and whether disciplined underwriting can sustain profit margins. The earnings beat on adjusted EPS, combined with in-line revenue, suggests the company is managing its expansion without sacrificing earnings quality. When I reviewed comparable names in the sector, I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Radian Group reported total revenue of $624.1 million for the third quarter of 2026, up 107% from the prior-year period and roughly in line with the consensus estimate of approximately $624.4 million. Net premiums earned, the company's primary revenue driver, surged 131% year over year to $548.3 million, reflecting the growing contribution from the Inigo specialty insurance business.
On the bottom line, adjusted diluted EPS came in at $1.44, exceeding analysts' consensus estimate of $1.21 by approximately 18.9%. GAAP diluted EPS from continuing operations was $1.28, compared with $0.87 in the same quarter last year. Pretax profit totaled $228.3 million, representing a 36.6% pretax margin. Book value per share increased 4.2% year over year to $35.78.
"Radian delivered an excellent third quarter, with strong contributions from both our Mortgage Insurance and Specialty Insurance businesses," said CEO Mike Weinbach. "Total revenue more than doubled year-over-year with the addition of Inigo, and the strategic rationale for the acquisition is already showing up in our results."
Investors responded favorably to the results, with RDN shares rising about 4.4% to roughly $38.20 in the immediate aftermath of the report. The positive reaction was driven primarily by the meaningful adjusted EPS beat, which signaled that the company's specialty insurance expansion is contributing to earnings faster than expected. The in-line revenue figure did not dampen sentiment, as the strong year-over-year growth trajectory reinforced confidence in the Inigo integration. Sentiment heading into the report had been cautious following a softer prior quarter, making the earnings beat a welcome catalyst. The market's interpretation suggests that investors are increasingly valuing Radian as a diversified specialty insurer rather than a pure mortgage insurance play.
Following this quarter, investors will be watching several factors that could shape Radian's trajectory. The continued integration and scaling of Inigo remains the central story. Management has previously signaled expectations for specialty premiums in the second half of 2026 to run roughly 20% above the first half, and the market will look for confirmation that this momentum carries into 2027.
Underwriting discipline in specialty insurance will also be closely watched. A softening specialty market has put pressure on combined ratios, the measure of an insurer's profitability that compares losses and expenses to premiums earned. Holding that ratio within management's targeted low-90s range will be key to preserving margins as the business grows.
On the mortgage insurance side, investors should monitor primary insurance in force and new insurance written, as housing market conditions and interest rates continue to influence origination volumes. Finally, capital management will remain in focus, given the company's significant financial flexibility, dividend guidance, and share buyback program. How Radian deploys capital across these priorities will help define the next phase of its diversification strategy.
I find Tickeron’s AI Screener helpful when evaluating how names like Radian compare on fundamentals and technical signals within the specialty insurance space. It lets me quickly filter for peers showing similar growth patterns or volatility profiles, which adds useful context to earnings reviews like this one without replacing deeper fundamental work.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The RSI Indicator for RDN moved out of oversold territory on October 02, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 19 similar instances when the indicator left oversold territory. In 16 of the 19 cases the stock moved higher. This puts the odds of a move higher at 84%.
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on RDN as a result. In 50 of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 61%.
The Moving Average Convergence Divergence (MACD) for RDN just turned positive on October 06, 2026. Looking at past instances where RDN's MACD turned positive, the stock continued to rise in 29 of 50 cases over the following month. The odds of a continued upward trend are 58%.
RDN moved above its 50-day moving average on October 23, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for RDN crossed bullishly above the 50-day moving average on October 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 16 of 24 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
Following a +5.21% 3-day Advance, the price is estimated to grow further. Considering data from situations where RDN advanced for three days, in 194 of 336 cases, the price rose further within the following month. The odds of a continued upward trend are 58%.
The Aroon Indicator entered an Uptrend today. In 143 of 260 cases where RDN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 55%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The 50-day moving average for RDN moved below the 200-day moving average on October 29, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RDN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.
RDN broke above its upper Bollinger Band on October 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is 22 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 56, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 38 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. RDN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 71 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.986) is normal, around the industry mean (1.006). P/E Ratio (9.166) is within average values for comparable stocks, (11.383). Projected Growth (PEG Ratio) (0.230) is also within normal values, averaging (0.944). Dividend Yield (0.028) settles around the average of (0.490) among similar stocks. P/S Ratio (2.960) is also within normal values, averaging (2.529).
The Tickeron SMR rating for this company is 88 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of credit-related insurance coverage and financial services
Industry SpecialtyInsurance